MétaCan
Menu
Back to cohort
Record W4412356022 · doi:10.1093/neuonc/noaf165

RANO seizure working group-Tumor-Related Epilepsy Assessment Tool (RANO-TREAT) to assess seizure control for glioma treatment trials and clinical practice

2025· article· en· W4412356022 on OpenAlexaff
Edward K. Avila, Anne S. Reiner, Terri S. Armstrong, Ashley Aaroe, Elizabeth Cunningham, Julia Brown, Francesco Bruno, Jose Diarte, Aya Haggiagi, Rebecca A. Harrison, Adela Joanta-Gomez, Johan A F Koekkoek, Eudocia Q. Lee, Emilie Le Guen, Hope Miller, Katherine S. Panageas, Edwin Peguero, Roberta Rudà, Riccardo Soffietti, Jessica W. Templer, Steven Tobochnik, Elizabeth Vera, Michael A. Vogelbaum, Michael Weller, Martin J. van den Bent

Bibliographic record

VenueNeuro-Oncology · 2025
Typearticle
Languageen
FieldMedicine
TopicGlioma Diagnosis and Treatment
Canadian institutionsBC Cancer FoundationUniversity of British ColumbiaBC Cancer Agency
FundersNational Center for Advancing Translational SciencesNational Institutes of HealthNational Cancer InstituteCleveland ClinicMedacEisaiLes Laboratories Pierre FabreLEO PharmaIncyteNovocureMoffitt Cancer CenterMemorial Sloan-Kettering Cancer CenterServierPfizer
KeywordsCohortMedicineGliomaEpilepsyPost-hoc analysisClinical trialCohort studyPhysical therapyInternal medicinePsychiatry

Abstract

fetched live from OpenAlex

BACKGROUND: No standardized method exists for seizure assessment in glioma clinical trials. We describe the development and evaluation of RANO-TREAT (Tumor Related Epilepsy Assessment Tool) for seizure assessment and its association with changes on brain MRI. METHODS: Patients with glioma/glioneuronal tumors and ≥ 1 prior seizure along with clinicians completed RANO-TREAT in conjunction with brain MRIs, yielding multiple RANO-TREAT scores at clinic visits over time. Unweighted (primary) and weighted (post-hoc) scores were correlated with disease progression via MRI in all patients and patients with IDHmt tumors, separately. Cohorts were randomly split by patient into cohort-specific training and validation sets. Weights for RANO-TREAT items were defined by multivariable generalized estimating equation models in cohort-specific training sets and validated in cohort-specific validation sets. A nomogram was developed using overall cohort training and validation sets. RESULTS: Four hundred and ninety patients (310 IDHmt tumors) had ≥ 1 visits and 285 patients (168 IDHmt tumors) had ≥ 2 visits. Unweighted RANO-TREAT scores (OR:1.01; 95%CI:0.998-1.02; P = .13) and score changes (OR:1.00; 95%CI:0.99-1.02; P = .63) were not associated with progressive disease on MRI. Post-hoc analysis using training and validation sets demonstrated weighted RANO-TREAT scores were correlated with progressive disease in both overall cohort validation set (OR:2.51; 95%CI:1.80-3.52; P < .0001) and IDHmt cohort validation set (OR:4.53; 95%CI:2.11-9.75; P = .0001). Weighted analyses for patients with ≥ 2 visits showed similar associations in validation sets. CONCLUSIONS: This prospective study suggests an association of seizure control evaluated by a new standardized tool with disease progression in glioma. This tool requires further systematic evaluation in glioma clinical trials alongside more traditional endpoints.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.144
metaresearch head score (Gemma)0.237
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesMetaresearch
Consensus categoriesnone
DomainCandidate signal: Methods · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Methods · Consensus signal: Methods
Teacher disagreement score0.856
Threshold uncertainty score0.760

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.1440.237
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0040.004
Bibliometrics0.0050.005
Science and technology studies0.0010.001
Scholarly communication0.0040.002
Open science0.0030.004
Research integrity0.0010.002
Insufficient payload (model declined to judge)0.0050.002

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.072
GPT teacher head0.439
Teacher spread0.367 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

Study designNot applicable
DomainMethods
GenreMethods

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations4
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueNeuro-OncologySame topicGlioma Diagnosis and TreatmentFrench-language works237,207